News

MediGene AG Appoints Dr. Frank Mathias as new Chief Executive Officer

MediGene AG (Frankfurt: MDG, Prime Standard, TecDAX) announces that Dr. Peter Heinrich, CEO and Chairman of the Executive Board of MediGene AG, has resigned from his position as member of the Executive Board with immediate effect. The Supervisory Board of MediGene AG has accepted the resignation and has appointed Dr. Frank Mathias, until now Chief Operating Officer of MediGene AG, as Chairman of the Executive Board of MediGene AG.    

 

 

 

This press release contains forward-looking statements representing the opinion of MediGene as of the date of this release. The actual results achieved by MediGene may differ significantly from the statements made herein. MediGene is not bound to update any of these forward-looking statements. MediGene® is a registered trademark of MediGene AG. This trademark may be owned or licensed in select locations only.

 

 

 

 

 

- ends -

 

 

 

Contact MediGene AG

 

E-mail: investor@medigene.com

 

Fax: +49 - 89 - 85 65 - 2920

 

Julia Hofmann / Dr. Nadja Wolf, Public Relations, Tel.: +49 - 89 - 85 65 - 3324

 

Dr. Georg Dönges, Investor Relations, Tel.: +49 - 89 - 85 65 - 2946